Johnson & Johnson (Ireland)

Recent papers from Johnson & Johnson (Ireland)

1. Teclistamab Plus Daratumumab Versus Standard Daratumumab-Based Proteasome Inhibitor Combinations for Relapsed/Refractory Multiple Myeloma: An Inverse Probability of Treatment Weighting AnalysisAdvances in Therapy · 2026
2. Purkinje De-networking to Treat Suspected Purkinje Originated PVC-triggered Ventricular Fibrillation.HeartRhythm Case Reports · 2026
3. First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survivalLeukemia · 2026
4. Real‐world radical cystectomy use in high‐risk non‐muscle‐invasive bladder cancer: a global surveyBJU International · 2026
5. Revolutionizing 2L+ Myeloma: A Podcast on the New Era of BCMA-Targeted Bispecific Antibody TherapiesAdvances in Therapy · 2026
6. Transradial versus transfemoral access in acute ischemic stroke thrombectomy: a meta-analysisJournal of NeuroInterventional Surgery · 2026
7. Real-World Treatment Patterns and Outcomes for Patients With Relapsed/Refractory Multiple Myeloma and Prior Exposure to Lenalidomide and Proteasome Inhibitors in the United StatesClinical Lymphoma Myeloma & Leukemia · 2026
8. Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: the phase 1b PALOMA studyClinical Lung Cancer · 2026
9. Abstract TP006: Procedural Variations and Failure Rates in Transradial vs Transfemoral Access for Acute Ischemic Stroke ThrombectomyStroke · 2026
10. Post-marketing study of patients to evaluate NIMBUS revascularization effectiveness with challenging occlusions (SPERO): study resultsJournal of NeuroInterventional Surgery · 2026
11. An in vitro assessment of aspiration technologies: Location of conduit for 6F aspiration catheters and design of catheter tip influence clot retrieval successInterventional Neuroradiology · 2025
12. Fixed-duration ibrutinib-venetoclax for first-line treatment of patients with chronic lymphocytic leukemia: the REALITY-WW prospective real-world study cohortFuture Oncology · 2025
13. Investigation into Clearance of Organic Compounds from Biomanufacturing Process Streams during Ultrafiltration/Diafiltration2025
14. Unmet Needs in Acute Ischemic Stroke: Overcoming Recalcitrant ClotsCardiology in Review · 2025
15. Decomposition heuristics for the Hybrid Flexible Flowshop with transportation timesComputers & Operations Research · 2025
16. Outcomes of Patients With Extramedullary Disease in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma From the Pooled LocoMMotion and MoMMent StudiesClinical Lymphoma Myeloma & Leukemia · 2025
17. Breaking the bias: perspectives of a WiSTEM²D programme inspiring female undergraduates for a technical futureEducation + Training · 2024
18. Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumabAnnals of Hematology · 2024
19. Bioprinting of scaled-up meniscal grafts by spatially patterning phenotypically distinct meniscus progenitor cells within melt electrowritten scaffoldsBiofabrication · 2023
20. Comparing Left Atrial Low Voltage Areas in Sinus Rhythm and Atrial Fibrillation Using Novel Automated Voltage Analysis: A Pilot StudyCardiology Research · 2023